124.65000 EUR
0.45
0.36%
Last update Dec 15, 7:30 PM CET
Main market
Day range
124.050003
125.70000
Previous close
124.20000
Open
125.55000
Access this stock data via API
Subscribe
Axsome Therapeutics, Inc.
124.65
0.45
0.36%

Financials

Income statement

Fundamentals currency is USD
Fiscal date 2024 2023 2022 2021
Total reported revenue 328.5M 270.6M 50.0M 0
Cost of revenue 28.4M 26.1M 5.2M 0
Gross profit 300.2M 244.5M 44.8M 0
Operating expense
Research & development 159.3M 97.9M 57.9M 58.1M
Selling general and admin 350.4M 323.1M 159.3M 66.6M
Other operating expenses
Operating income -215.0M -182.9M -176.5M -124.7M
Non operating interest income
Income
Expense 5.6M 6.5M 7.3M 5.7M
Other income expense -24.0M -48.9M -3.3M
Pretax income -244.6M -238.3M -187.1M -130.4M
Tax provision 72.4K 960K 0 0
Net income -244.6M -239.2M -187.1M -130.4M
Basic EPS -6.0 -5.3 -4.6 -3.5
Diluted EPS -6.0 -5.3 -4.6 -3.5
Basic average shares 40.8M 47.3M 42.3M 39.2M
Diluted average shares 40.8M 47.3M 42.3M 39.2M
EBITDA -208.2M -176.1M -172.1M -124.6M
Net income from continuing op. -244.6M -239.2M -187.1M -130.4M
Minority interests
Preferred stock dividends
Access the full /income_statement historical dataset via the API — starting from the Pro plan.
Main market

Exchange is currently active.
Closing in 5 hours 39 minutes

14:20
00:00
08:00
20:00
23:59

Trading Hours (Monday - Friday):

Main market
08:00 - 20:00
All times are displayed in the Europe/Berlin timezone (CET, UTC+01:00).